Frontlight ResearchEarly access
Trial site
Nanjing Medical University - Nanjing Jiangning Hospital
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Type 2 diabetes3 trials
- Ulcerative colitis3 trials
- Asthma1 trial
- Osteoarthritis1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026